FDA Warns Abiomed About Unlawful Promotion Of Impella Cardiac Pump
This article was originally published in The Gray Sheet
Executive Summary
FDA says Abiomed is promoting its top-selling Impella 2.5 cardiac pump for unapproved uses, and sent a warning letter to the firm June 10.